Xilio Therapeutics (XLO) Institutional Ownership $0.94 -0.08 (-7.83%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Xilio Therapeutics (NASDAQ:XLO)CurrentInstitutional OwnershipPercentage54.29%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$229.46KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.20M Get XLO Insider Trade Alerts Want to know when executives and insiders are buying or selling Xilio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data XLO Institutional Buying and Selling by Quarter Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Xilio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC338,192$266K0.0%+85.0%0.769% 8/12/2024 XTX Topco Ltd33,289$32K0.0%N/A0.076% 8/9/2024 Renaissance Technologies LLC295,000$280K0.0%+18.3%0.799% 5/6/2024 Atlas Venture Life Science Advisors LLC992,912$1.07M0.1%-64.0%2.690% 4/22/2024 PFG Investments LLC30,000$32K0.0%N/A0.087% 2/15/2024 Octagon Capital Advisors LP1,785,000$982K0.2%-23.0%6.481% 11/14/2022Ergoteles LLC12,941$38K0.0%-26.3%0.047% 8/15/2022 Laurion Capital Management LP142,900$417K0.0%N/A0.520% 7/27/2022 Bailard Inc.36,632$107K0.0%N/A0.133% 5/16/2022 Deerfield Management Company L.P. Series C2,078,692$14.70M0.3%-3.5%7.567% 5/12/2022 Monashee Investment Management LLC163,066$1.15M0.3%-23.9%0.594% 2/15/2022 Davidson Kempner Capital Management LP29,000$458K0.0%N/A0.109% 2/14/2022 Deerfield Management Company L.P. Series C2,154,061$33.74M0.7%N/A8.078% 2/14/2022 Ghisallo Capital Management LLC30,000$480K0.0%N/A0.113% 2/14/2022 Soleus Capital Management L.P.477,495$7.64M0.8%N/A1.791% 2/11/2022Granite Point Capital Management L.P.10,000$160K0.0%N/A0.038% 2/9/2022AJU IB Investment Co. Ltd.667,742$10.68M14.9%N/A2.504% 2/8/2022 Northern Trust Corp63,034$1.01M0.0%N/A0.236% 2/7/2022 Monashee Investment Management LLC214,253$3.43M0.8%N/A0.803% 2/7/2022 RiverVest Venture Management LLC1,441,444$23.06M16.5%N/A5.406% 2/2/2022 New York State Common Retirement Fund5,568$89K0.0%N/A0.021% (Data available from 1/1/2016 forward) XLO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of XLO shares? During the previous two years, the following institutional investors and hedge funds held shares of Xilio Therapeutics shares: Atlas Venture Life Science Advisors LLC ($1.07M), Octagon Capital Advisors LP ($982K), Renaissance Technologies LLC ($280K), Geode Capital Management LLC ($266K), and XTX Topco Ltd ($32K), PFG Investments LLC ($32K).Learn more on XLO's institutional investors. What percentage of Xilio Therapeutics stock is owned by institutional investors? 54.29% of Xilio Therapeutics stock is owned by institutional investors. Learn more on XLO's institutional investor holdings. Which institutional investors have been buying Xilio Therapeutics stock? The following institutional investors have purchased Xilio Therapeutics stock in the last 24 months: Geode Capital Management LLC ($155.34K), Renaissance Technologies LLC ($45.55K), XTX Topco Ltd ($33.29K), and PFG Investments LLC ($30K). How much institutional buying is happening at Xilio Therapeutics? Institutional investors have bought a total of 264,180 shares in the last 24 months. This purchase volume represents approximately $229.46K in transactions. Which Xilio Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Xilio Therapeutics stock in the last 24 months: Atlas Venture Life Science Advisors LLC ($1.77M), and Octagon Capital Advisors LP ($533.50K). How much institutional selling is happening at Xilio Therapeutics? Institutional investors have sold a total of 2,299,932 shares in the last 24 months. This volume of shares sold represents approximately $2.20M in transactions. Related Companies NBTX Institutional Ownership VSTM Institutional Ownership SCPH Institutional Ownership NKTX Institutional Ownership GALT Institutional Ownership DMAC Institutional Ownership LFVN Institutional Ownership ACTU Institutional Ownership GLSI Institutional Ownership TSVT Institutional Ownership This page (NASDAQ:XLO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xilio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XLO Stock Alerts